Escalon Medical Corp.  

(Public, NASDAQ:ESMC)   Watch this stock  
Find more results for ESMC
0.00 (0.00%)
Jan 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.34 - 1.34
52 week 1.22 - 2.39
Open 1.34
Vol / Avg. 100.00/3,529.00
Mkt cap 11.06M
P/E     -
Div/yield     -
EPS -0.11
Shares 7.53M
Beta -0.83
Inst. own 15%

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -16.74% -2.83%
Operating margin -16.74% -2.89%
EBITD margin - -2.80%
Return on average assets -24.28% -4.68%
Return on average equity -54.44% -9.59%
Employees 58 -
CDP Score - -


Suite 200, 100 Church Street
United States - Map
+1-610-6886830 (Phone)
+1-610-6883641 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Escalon Medical Corp. (Escalon), operates in the healthcare market, specializing in the development, manufacture marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes and hematology. The Company�s segments include Escalon Clinical Diagnostics (ECD), Sonomed-Escalon and Escalon Medical Corp. The Escalon Clinical Diagnostics (ECD) segment consists of Drew Scientific, Inc., and its wholly owned subsidiaries JAS Diagnostics, Inc. (JAS) and Biocode Hycel (Biocode). The Sonomed-Escalon segment consists of Sonomed, EMI and Trek, all of which are engaged in the development and sale of Ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations of the consolidated group. In October 2012, ERBA Diagnostics, Inc. acquired the Clinical Diagnostics Business from Escalon.

Officers and directors

Richard J. DePiano Jr. Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Richard J. DePiano Jr. President, Chief Executive Officer, General Counsel, Director
Age: 47
Bio & Compensation  - Reuters
Robert M. O'Connor Chief Financial Officer
Age: 52
Bio & Compensation  - Reuters
Mark G. Wallace Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Fred G. Choate Independent Director
Age: 68
Bio & Compensation  - Reuters
C. Sean Closkey Independent Director
Age: 46
Bio & Compensation  - Reuters
William L.G. Kwan Independent Director
Age: 73
Bio & Compensation  - Reuters
Lisa A. Napolitano Independent Director
Age: 48
Bio & Compensation  - Reuters